Ann J. Barbier
Directeur/Membre du Conseil chez PIERIS PHARMACEUTICALS, INC.
Fortune : - $ au 30/04/2024
Profil
Ann J.
Barbier is currently an Independent Director at Pieris Pharmaceuticals, Inc. since 2018 and a Director at Vicore Pharma Holding AB since 2024.
Previously, she held positions such as Senior Director-Medical at Shire Human Genetic Therapies, Inc. from 2007 to 2011, Vice President-Clinical Development at Agios Pharmaceuticals, Inc. from 2015 to 2017, Chief Medical Officer at Translate Bio, Inc. from 2017 to 2021, Global Lead-Clinical Development at Shire Pharmaceuticals, Inc. from 2014 to 2015, and Chief Medical Officer at Camp4 Therapeutics Corp.
from 2022 to 2023.
Dr. Barbier obtained a doctorate degree from Ghent University in 1985 and a graduate degree from Université Libre de Bruxelles in 1995.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/06/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Ann J. Barbier
| Sociétés | Poste | Début |
|---|---|---|
| PIERIS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 25/04/2018 |
| VICORE PHARMA HOLDING AB | Directeur/Membre du Conseil | 07/05/2024 |
Anciens postes connus de Ann J. Barbier
| Sociétés | Poste | Fin |
|---|---|---|
Camp4 Therapeutics Corp.
 Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Directeur Technique/Scientifique/R&D | 01/10/2023 |
| TRANSLATE BIO, INC. | Directeur Technique/Scientifique/R&D | 14/09/2021 |
| AGIOS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/10/2017 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Directeur Technique/Scientifique/R&D | 01/05/2015 |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Corporate Officer/Principal | 01/02/2011 |
Formation de Ann J. Barbier
| Ghent University | Doctorate Degree |
| Université Libre de Bruxelles | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| PIERIS PHARMACEUTICALS, INC. | Health Technology |
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| VICORE PHARMA HOLDING AB | Health Technology |
| Entreprise privées | 4 |
|---|---|
Translate Bio, Inc.
 Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Health Technology |
Camp4 Therapeutics Corp.
Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
